Feb 24, 2021 / 09:30PM GMT
Operator
Greetings, and welcome to the Aurinia Year-end 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is recorded.
It's now my pleasure to turn the call over to Glenn Schulman, Senior Vice President, Investor Relations. Please go ahead, sir.
Glenn Schulman - Aurinia Pharmaceuticals Inc. - SVP of Corporate Communications & IR
Thank you, Kevin, and good afternoon, everyone. I'm pleased to welcome you to today's call discussing Aurinia's fourth quarter and year-end financial results. Joining me on the call this afternoon are Peter Greenleaf, President and CEO of Aurinia; Neil Solomons, our Chief Medical Officer; Max Colao, Chief Commercial Officer; and Joe Miller, our Chief Financial Officer.
This afternoon, just after 4:00 p.m., we issued our press release announcing our financial results and recent operational highlights, which is accessible from our website at www.auriniapharma.com. And has been filed on our Form 8-K with the SEC
Q4 2020 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Feb 25, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers